Expression of the HGF/SF Receptor, c-met, and Its Ligand in Human Colorectal Cancers

References

• Cooper C S, Park M, Blair D G, et al. Molecular cloning of a new transforming gene from a chemically-transformed human cell line. Nature 1984; 311: 29–33
   PubMed Web of Science ®Google Scholar
• Bottaro D P, Rubin J S, Faletto D L, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802–804
   PubMed Web of Science ®Google Scholar
• Jung W, Castren E, Odenthal M. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 1994; 126: 485–94
   PubMed Web of Science ®Google Scholar
• Giordano S, Ponzetto C, Di Renzo M F, et al. Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989; 339: 155–156
   PubMed Web of Science ®Google Scholar
• Giordano S, Di Renzo M F, Narsimhan R, et al. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 1989; 4: 1383–1388
   PubMed Web of Science ®Google Scholar
• Tempest P R, Cooper C S, Major G N, et al. Structure of the met protein and variation of met protein kinase activity among human tumor cell lines. Br J Cancer 1988; 58: 3–7
   PubMed Web of Science ®Google Scholar
• Park M, Dean M, Kaul K. Sequence of met protooncogene cDNA has features characteristic of the tyrosine kinase family of growth factor receptors. Proc Natl Acad Sci USA 1987; 84: 6379–6383
   PubMed Web of Science ®Google Scholar
• Gonzatti-Aces M, Seth A, Park M, et al. Characterization of the TPR-MET oncogene p65 and the met protooncogene p140 protein tyrosine kinases. Proc Natl Acad Sci USA 1988; 85: 21–25
   PubMed Web of Science ®Google Scholar
• Naldini L, Vigna E, Narshiman R P, et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-met. Oncogene 1991; 6: 501–504
   PubMed Web of Science ®Google Scholar
• Prat M, Narsimhan P R, Crepaldi T, et al. The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 1991; 49: 323–328
   PubMed Web of Science ®Google Scholar
• Di Renzo M F, Olivero M, Ferro S, et al. Overexpression of the c-met /HGF receptor gene in human thyroid cancers. Oncogene 1992; 7: 2549–2553
   PubMed Web of Science ®Google Scholar
• Di Renzo M F, Poulsom R, Olivero M, et al. Expression of the met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 1995; 55: 1129–1138
   PubMed Web of Science ®Google Scholar
• Ebert M, Yokoyama M, Friess H, et al. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994; 54: 5775–5778
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450–1459
   PubMed Web of Science ®Google Scholar
• Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culatures. Proc Natl Acad Sci USA 1986; 86: 6489–6493
   Google Scholar
• Stoker M, Perryman M. An epithelial scatter factor released by embryo fibrobasts. J Cell C Sci 1985; 77: 209–223
   PubMed Web of Science ®Google Scholar
• Gherardi E, Stoker M. Hepatocytes and scatter factor. Nature 1990; 346: 228, letter
   PubMed Web of Science ®Google Scholar
• Weidner K M, Behrens J, Vandekerckhove J, et al. Scatter factor: Molecular characteristics and the effect on the invasiveness of epithelial cells. J Cell Biol 1990; 111: 2097–2108
   PubMed Web of Science ®Google Scholar
• Weidner K M, Akaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001–7005
   PubMed Web of Science ®Google Scholar
• Stoker M, Gherardi E, Perryman M, et al. Scatter factor is a fibrobast-derived modulator of epithelial cell motility. Nature 1987; 327: 239–242
   PubMed Web of Science ®Google Scholar
• Noji S, Tashiro K, Koyama E, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173: 42–47
   PubMed Web of Science ®Google Scholar
• Shima N, Itagaki Y, Nagao M, et al. A fibroblast-derived tumor cytotoxic factor/F-TCF (Hepatocyte growth factor/HGF) has multiple functions in vitro. Cell Biol Int Rep 1991; 15: 379–408
   Google Scholar
• Yoshinaga Y, Fujita S, Gotoh M, et al. Human lung-cancer cell line producing hepatocyte growth factor/scatter factor. Jpn J Cancer Res 1992; 83: 1257–1261
   PubMedGoogle Scholar
• Jiang W G, Lloyds D, Puntis, et al. Regulation of spreading and growth of human colon cancer cells by hepatocyte growth factor. Clin Exp Metast 1993; 11: 235–242
   PubMed Web of Science ®Google Scholar
• Shibamoto S, Hayakawa M, Hori T. Hepatocyte growth factor and transforming growth factor-(stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell Struc Funct 1992; 17: 185–190
   PubMed Web of Science ®Google Scholar
• Bussolino F, Di Renzo M F, Ziche M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629–641
   PubMed Web of Science ®Google Scholar
• Rosen E M, Meromsky L, Setter E, et al. Purified scatter factor stimulates epithelial and vascular endothelial cell migration. Proc Soc Exp Biol Med 1990; 195: 34–43
   PubMed Web of Science ®Google Scholar
• Nagaike M, Hirao S, Tajima H, et al. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 1991; 266: 22781–22784
   PubMed Web of Science ®Google Scholar
• Comoglio P M, Di Renzo M F, Naldini L. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biochem 1993; 17A: 232–235
   Google Scholar
• Grant D S, Kleinman H K, Goldberg I D. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937–1941
   PubMed Web of Science ®Google Scholar
• Jiang W G, Hiscox S, Hallett M B, et al. Inhibition of hepatocyte growth factor/scatter factor induced motility and invasion of human cancer cells by gamma linolenic acid. Br J Cancer 1995; 71: 744–752
   PubMed Web of Science ®Google Scholar
• Lindroos P M, Zamegar R, Michalopoulos G K. Hepatocyte growth factor (hepatopoietin A) rapidly increase in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991; 13: 743–749
   PubMed Web of Science ®Google Scholar
• Gohda E, Tsubouch H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414–419
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Toi M, Inada K, et al. Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1995; 1: 1031–1034
   PubMed Web of Science ®Google Scholar
• Donaldson G A, Welch J P. Management of cancer of the colon. Surg Clin North Am 1974; 54: 713–730
   PubMed Web of Science ®Google Scholar
• Eisenberg B, De Cosse J J, Harford F, et al. Carcinoma of the colon and rectum-The natural history reviewed in 1704 patients. Cancer 1982; 49: 1131–1134
   PubMed Web of Science ®Google Scholar
• Allen-Mersh T G. Colorectal liver metastases. J Roy Soc Med 1989; 82: 2–3
   PubMed Web of Science ®Google Scholar
• August D A, Ottow R T, Sugarbaker P H. Clinical perspective of human colorectal cancer metastases. Cancer Metast Rev 1984; 3: 303–324
   PubMed Web of Science ®Google Scholar
• Schiffman E. Motility as a principal requirement for metastasis. Cancer Invest 1990; 8: 673–674
   PubMed Web of Science ®Google Scholar
• Higuchi O, Mizuno K, Vande Woude G F, et al. Expression of c-met proto-oncogene in COS cells induces the signal transducing high affinity receptor for hepatocyte growth factor. FEBS Lett 1992; 301: 282–286
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440–443
   PubMed Web of Science ®Google Scholar
• Chonmczynski P, Sacchi N. A single step method of RNA isolation by acid guanidimium thiosulphate-phenol-chloroform extraction. Analyt Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Joseph A, Weiss G H, Jin L, et al. Expression of scatter factor in human bladder carcinoma. J Natl Cancer Inst 1995; 87: 372–377
   PubMed Web of Science ®Google Scholar
• Pisters L L, Troncoso P, Zhau H E, et al. c-met proto-oncogene expression in benign and malignant human prostrate tissues. J Urol 1995; 154: 293–298
   PubMed Web of Science ®Google Scholar
• Humphrey P A, Zhu X, Zarnegar R, et al. Hepatocyte growth factor and its receptor (c-met) in prostatic carcinoma. Am J Pathol 1995; 147: 386–396
   PubMed Web of Science ®Google Scholar
• Giordano S, Zhen Z, Medico E, et al. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human met protooncogene. Proc Natl Acad Sci USA 1993; 90: 649–653
   PubMed Web of Science ®Google Scholar
• Rong S, Bodescot M, Blair D, et al. Tumourigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 1992; 12: 5152–5158
   PubMed Web of Science ®Google Scholar
• Liu C, Park M, Tsao M S. Overexpression of c-met protooncogene but not epidermal growth factor receptor or c-erbb-2 in primary human colorectal carcinomas. Oncogene 1992; 7: 181–185
   PubMed Web of Science ®Google Scholar
• Shiota G, Okano J, Kawasaki H, et al. Serum hepatocyte growth factor levels in liver diseases: Clinical implications. Hepatology 1995; 21: 106–112
   PubMed Web of Science ®Google Scholar
• Nakamura S, Gohda E, Matsuo Y, et al. Significant amounts of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients. Br J Haematol 1994; 87: 640–642
   PubMed Web of Science ®Google Scholar
• Abulafi A M, Williams N S. Local recurrence of colorectal cancer: The problem, the mechanisms, management and adjuvant therapy. Br J Surg 1994; 81: 7–19
   PubMed Web of Science ®Google Scholar
• Goligher J C. Treatment of carconma of the colon. Surgery of the Anus, Rectum and Colon, 5th ed. Bailliere Tindall, London 1984; 549–550
   Google Scholar
• Jass J R, Love S B, Northover J MA. A new prognostic classification in rectal cancer. Lancet 1987; 1: 1303–1306
   PubMed Web of Science ®Google Scholar
• Nakamori S, Ota D M., Cleary K R, et al. MUCl mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994; 106: 353–364
   PubMed Web of Science ®Google Scholar
• Remvikos Y, Tomiaga O, Hammel P. Increased p53 protein content of colorectal tumors correlates with poor survival. Br J Cancer 1992; 6: 758–764
   Google Scholar
• Comoglio P M. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. Experientia Supplimenta 1993; 65: 131–165
   PubMedGoogle Scholar